Tevogen

Business

Tevogen Bio reports series A-1 preferred stock investment at $10 conversion price

Tevogen Bio (NASDAQ:TVGN) Thursday said it entered into a securities purchase agreement with an existing investor. Under the agreement, the…

Read More »
Back to top button